|
MechanismZIKV E protein inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with GSK Vaccines Vertriebs GmbH
0 Patents (Medical) associated with GSK Vaccines Vertriebs GmbH
100 Deals associated with GSK Vaccines Vertriebs GmbH
100 Translational Medicine associated with GSK Vaccines Vertriebs GmbH